Drug Discovery ELRIG 2025October 2025Infectious DiseasesCell & 3D modelsPoster code 25023

About this poster
Coronaviruses rely on a unique process called discontinuous transcription to generate subgenomic RNAs essential for viral replication. This poster introduces a stable cell-based model of coronavirus replication, designed with a SARS-CoV replicon and NanoLuciferase reporter, enabling high-throughput screening for inhibitors of this process. Learn how phenotypic screening, supported by extensive follow-up assays, provides a framework for discovering potential pan-coronavirus antivirals.
Get the full poster
Free PDF, sent to your work email.
Phenotypic screen poster, code 25023
Related posters
June 2026, code 26013A Functional Human iPSC-Derived Blood–Brain Barrier Model to Predict CNS Drug PenetrationPRIM-TECH3RJune 2026, code 26014-15C3PO: Complex 3D Patient Organoids for Preclinical Drug Testing in Brain TumorsPRIM-TECH3R & BaCell 2026June 2025, code 25014A Platform for Comprehensive CRISPR/Cas9 Genome Editing in Preclinical Research and Drug DiscoverySIBBM Frontiers in Molecular Biology 2025

